PainChek Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PCK.AX research report →
Price Chart
About the company
PainChek Limited specializes in the creation and commercialization of mobile medical applications designed for individual pain assessment. Their core product, PainChek, employs smartphone and tablet cameras to record video, which is then analyzed in real-time by facial recognition software to detect the presence of pain. This technology is particularly beneficial for patients suffering from dementia.
- CEO
- Philip Daffas
- IPO
- 2012
- Employees
- 25
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on PCK.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $20.48M
- P/E
- -2.79
- PEG
- -0.13
- P/S
- 7.92
- P/B
- 8.00
- EV/EBITDA
- -2.26
- Div Yield
- 0.00%
- Gross Margin
- 28.38%
- Op Margin
- -271.56%
- Net Margin
- -269.13%
- ROE
- -1009.84%
- ROIC
- -280.32%
Latest fiscal year · YoY change
- Revenue
- $3.36M+25.8%
- Gross Profit
- $997.74K+37.3%
- Op Income
- $-9,111,843
- Net Income
- $-7,672,226+7.7%
- EPS
- $-0.04+21.4%
- OCF Growth
- +5.2%
- FCF Growth
- +5.5%
- 52W High
- $1.05
- 52W Low
- $0.10
- 50D MA
- $0.10
- 200D MA
- $0.20
- Beta
- 0.47
- RSI (14)
- 44
- Avg Volume
- 154.08K
No earnings-call transcripts are available for PCK.AX yet.
- Free Float
- 96.2%
- Shares Outstanding
- 209.01M
- Float Shares
- 201.08M
Our PCK.AX coverage
Recent articles, reports, and earnings notes.
No research on PCK.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PCK.AX report →